How to Get Spironolactone in Florida: Telehealth, Prescribers, and Pharmacy Access

How to Get Spironolactone in Florida
At a glance
- Prescription type / Prescription-only (Schedule: unscheduled)
- Florida telehealth prescribing / Fully permitted with audio-video visit
- Prescriber types / MDs, DOs, ARNPs, and PAs can all prescribe
- Typical acne dose / 50 to 200 mg daily
- Required labs / Serum potassium and basic metabolic panel (BMP)
- Generic cost (cash) / $4 to $15 per month at most Florida pharmacies
- Florida Medicaid / Generally not covered for acne (off-label indication)
- Compounding (503A) / Available through Florida-licensed 503A pharmacies
- Time to fill / Same day at retail; 3 to 7 business days via mail-order
- Time to visible results / 3 to 6 months for meaningful acne clearance
Who Can Prescribe Spironolactone in Florida
Any provider with an active Florida prescriptive authority license can write a spironolactone prescription. This includes physicians (MD/DO), advanced registered nurse practitioners (ARNPs), and physician assistants (PAs).
Florida ARNPs gained full independent practice authority under HB 607 (effective July 2020), meaning nurse practitioners no longer require a physician supervisory protocol to prescribe non-controlled medications like spironolactone [1]. PAs in Florida still prescribe under a supervising physician but may independently manage ongoing refills within the scope of their practice agreement.
Dermatologists are the most common prescribers, but the drug is also frequently ordered by primary care providers, OB-GYNs, and endocrinologists. A 2017 retrospective analysis found that dermatologists prescribed 42% of spironolactone written for acne in women, while primary care clinicians accounted for 35% of all prescriptions [2]. Because spironolactone is used off-label for acne (its FDA-approved indications are heart failure, hypertension, and primary hyperaldosteronism), any licensed prescriber comfortable with its safety profile may initiate therapy [3].
If you do not have an existing dermatologist in Florida, a telehealth consultation is the fastest route. Many board-certified providers licensed in Florida accept new patients for hormonal acne evaluations within 24 to 72 hours.
How Florida Telehealth Laws Apply to Spironolactone
Florida permits licensed prescribers to diagnose and prescribe through telehealth for non-controlled substances. Spironolactone is not a controlled substance, so it qualifies.
Under Florida Statute 456.47, a telehealth provider must hold an active Florida license (or be registered as an out-of-state telehealth provider) and establish a patient relationship via a real-time, two-way audio-video encounter before prescribing [4]. Phone-only visits are not sufficient for a first prescription. After the initial video consultation, follow-up visits and refills may be managed via asynchronous communication or audio-only calls at the provider's discretion.
The prescriber must document the encounter to the same standard as an in-person visit. This includes a history of present illness, review of acne severity, discussion of contraceptive status (spironolactone is FDA Pregnancy Category X due to anti-androgenic teratogenicity), and a plan for baseline labs [3]. Multiple telehealth dermatology platforms now serve Florida, and several have Florida-licensed pharmacists who can ship directly to your address.
Wait times vary by platform. Some direct-to-consumer services offer same-day consultations, while academic-affiliated telehealth programs typically schedule within one to two weeks. Check that the platform explicitly lists spironolactone in its formulary before booking, because a small number of teledermatology services limit prescribing to topicals only.
Required Lab Work Before Starting Spironolactone
Your prescriber will order a baseline metabolic panel before initiating spironolactone. This is non-negotiable.
Spironolactone is a potassium-sparing diuretic that blocks aldosterone receptors in the renal collecting duct. It can raise serum potassium, and hyperkalemia above 5.5 mEq/L carries cardiac risk [5]. The Endocrine Society and multiple dermatology consensus documents recommend checking serum potassium and creatinine at baseline, again at 4 to 8 weeks, and then annually for stable patients [6].
A 2015 retrospective study of 974 healthy young women (ages 18 to 45) taking spironolactone 25 to 200 mg daily found a hyperkalemia rate of only 0.72%, and no episodes requiring emergency intervention [7]. The authors concluded that routine serial monitoring may be unnecessary in young women with normal renal function, though most Florida prescribers still order at least two checks in the first year to satisfy standard-of-care documentation. A separate 2019 cohort of 1,802 women under 46 on spironolactone for acne confirmed a clinically significant hyperkalemia rate of just 0.13%, reinforcing the drug's favorable safety window in this population [8].
Florida lab orders can be completed at Quest Diagnostics, Labcorp, or any CLIA-certified draw site. Most telehealth platforms will send a lab requisition digitally, and results typically return within 24 to 48 hours. If your potassium is above 5.0 mEq/L at baseline, your provider will likely investigate the cause before prescribing.
How Spironolactone Treats Hormonal Acne
Spironolactone works by blocking androgen receptors and reducing androgen production. This is why it specifically targets hormonal acne in adult women.
Androgens (primarily testosterone and dihydrotestosterone) increase sebum production in pilosebaceous units. Excess sebum creates an environment favorable to Cutibacterium acnes colonization, inflammation, and comedone formation. Spironolactone competes with testosterone and DHT at the androgen receptor, reducing sebaceous gland activity by 30% to 50% depending on dose [9]. It also inhibits 5-alpha-reductase, the enzyme that converts testosterone to the more potent DHT [10].
A 2017 systematic review published in the British Journal of Dermatology evaluated the evidence for spironolactone in female acne and found response rates between 50% and 100% across included studies, though the authors noted a lack of large randomized controlled trials [11]. The British Association of Dermatologists guidelines list spironolactone as a recommended treatment for adult female acne that has not responded to conventional topical and oral therapies [11].
A 2020 randomized trial published in the BMJ (N=410) compared spironolactone 50 mg, titrated to 100 mg, against placebo in women with facial acne. At 24 weeks, 19.2% of the spironolactone group achieved a clear or almost-clear rating on the Acne-Specific Quality of Life scale compared to 5.8% on placebo [12]. Response improved further by week 52. This trial (SAFA) remains the largest placebo-controlled RCT for spironolactone in acne to date.
Spironolactone is not appropriate for male acne patients due to feminizing side effects including gynecomastia and sexual dysfunction.
Dosing Protocol and Timeline to Results
Most Florida dermatologists start at 25 to 50 mg daily and titrate upward based on response and tolerability. Full effect takes 3 to 6 months.
The typical dose range for hormonal acne is 50 to 200 mg per day, taken once or divided into two doses [13]. Starting low minimizes side effects (dizziness, breast tenderness, and irregular menstruation are common in the first four weeks). A retrospective cohort of 395 women showed that 200 mg daily produced an 85% improvement rate compared to 50% at 50 mg daily, though the higher dose also increased the frequency of menstrual irregularities from 12% to 28% [14].
Expect a realistic timeline. At weeks 4 to 6, new inflammatory lesions should decrease in frequency. By month 3, most patients notice fewer deep cystic breakouts along the jawline and chin. Maximal clearing typically occurs between months 4 and 6 [11]. Acne often recurs within 2 to 3 months of discontinuation, so many women remain on spironolactone as long-term maintenance therapy.
Your prescriber may combine spironolactone with a topical retinoid (tretinoin or adapalene) or oral contraceptive to accelerate results. Combined oral contraceptives containing drospirenone already provide some anti-androgenic activity, and the combination with spironolactone has shown additive benefit in observational data [15]. However, because drospirenone itself is a spironolactone analog, providers will monitor potassium more closely with this pairing.
Insurance Coverage and Out-of-Pocket Cost in Florida
Generic spironolactone is one of the least expensive prescription acne treatments available. Coverage depends on your insurer and the documented indication.
Most Florida commercial insurance plans (Blue Cross Blue Shield of Florida, Aetna, Cigna, UnitedHealthcare) cover generic spironolactone with a Tier 1 copay of $0 to $15 for a 30-day supply when prescribed for a covered indication like hypertension or heart failure [3]. When prescribed specifically for acne (ICD-10 code L70.0), some plans require prior authorization because the use is off-label. Your prescriber can often satisfy prior authorization by documenting failure of at least one topical retinoid and one antibiotic.
Florida Medicaid (managed by plans including Sunshine Health, Molina, and Staywell) covers spironolactone for heart failure and hypertension but generally does not cover it for acne or hirsutism. If you are on Medicaid, a GoodRx or RxSaver discount card may bring the cash price to $4 to $9 at Publix, Walmart, or CVS locations statewide.
Without any insurance, spironolactone costs roughly $8 to $15 per month for 50 mg tablets (quantity 30) at major Florida retail chains [16]. Costco pharmacies in Florida consistently offer some of the lowest cash prices, and no membership is required to use the pharmacy. The FDA Orange Book lists over 20 approved generic manufacturers for spironolactone tablets, which keeps pricing competitive [17].
Pharmacy Options and 503A Compounding in Florida
You can fill a spironolactone prescription at any Florida-licensed retail, mail-order, or compounding pharmacy.
Retail chains (CVS, Walgreens, Publix, Walmart) carry generic spironolactone tablets in 25 mg, 50 mg, and 100 mg strengths. Same-day fills are typical because the drug is widely stocked. Mail-order pharmacies (Express Scripts, OptumRx, Amazon Pharmacy) can deliver to any Florida address within 3 to 7 business days, often at a lower 90-day supply cost.
Florida's Board of Pharmacy licenses 503A compounding pharmacies under Chapter 465, Florida Statutes, with strict oversight from the Florida Department of Health [18]. A 503A pharmacy can compound spironolactone into alternative formulations (topical creams, flavored suspensions, or custom-dose capsules) when a prescriber writes a patient-specific prescription. Topical spironolactone 5% cream has shown localized anti-androgenic effects in small studies and may be an option for patients who experience systemic side effects from oral therapy [19].
A few caveats apply to compounded formulations. Compounded drugs are not FDA-approved, and payers rarely cover them [20]. Out-of-pocket cost for a compounded spironolactone preparation typically ranges from $30 to $80 per month depending on the pharmacy and formulation.
Safety Profile, Side Effects, and Ongoing Monitoring
Spironolactone is well-tolerated in healthy young women at dermatologic doses, but it carries specific risks that require monitoring.
The most common side effects in the 50 to 100 mg range include diuresis and increased urination (especially in the first two weeks), breast tenderness (up to 17% of patients), menstrual irregularities (10% to 30%), dizziness, and mild headache [7]. These effects are dose-dependent and often resolve with continued use or dose adjustment.
Hyperkalemia remains the primary safety concern. The FDA prescribing information carries a boxed warning about tumor risk based on chronic high-dose rodent studies, but epidemiologic data in humans have not confirmed an increased cancer risk at typical dermatologic doses [3]. A large 2024 population-based cohort study (N = 420,546 women, median follow-up 6.7 years) found no increased incidence of breast, ovarian, or uterine cancer among spironolactone users compared to matched controls [21].
Patients should avoid potassium supplements and potassium-rich salt substitutes while on spironolactone. Concurrent use of ACE inhibitors, ARBs, or NSAIDs requires closer potassium monitoring because these drugs independently raise potassium levels [5]. Your Florida prescriber should review your medication list at each visit.
Reliable contraception is required during treatment. Spironolactone crosses the placenta and can feminize a male fetus. The American Academy of Dermatology does not mandate concurrent oral contraceptives, but many dermatologists prescribe them together for both contraceptive and synergistic anti-acne benefit [22].
How to Transfer a Spironolactone Prescription to Florida
If you have an existing spironolactone prescription from another state, transferring it to a Florida pharmacy is straightforward.
Contact any Florida pharmacy (retail or mail-order) and provide the pharmacy name, phone number, and prescription number from your current out-of-state pharmacy. The Florida pharmacist will call the originating pharmacy to initiate the transfer under the standard inter-state prescription transfer protocol. Florida law permits the transfer of non-controlled prescription medications from pharmacies in any U.S. state [18].
Refills must remain on the original prescription. If your prescription has zero refills remaining, a Florida-licensed provider will need to write a new prescription. This can be accomplished via a telehealth visit as described above. The entire process, from booking a telehealth appointment to picking up a filled prescription, can typically be completed within 48 to 72 hours if labs are already on file.
One important detail: if your out-of-state prescription was written by a provider who is not licensed in Florida, the prescription itself is still valid at Florida pharmacies for non-controlled medications. The prescriber does not need a Florida license for the pharmacy to dispense, although your insurer may require a Florida-licensed provider for coverage purposes.
Frequently asked questions
›How do I get a spironolactone prescription in Florida?
›What labs are needed before spironolactone in Florida?
›Are there telehealth providers in Florida prescribing spironolactone?
›How long until I receive spironolactone in Florida?
›Can I transfer a spironolactone prescription to Florida?
›Are 503A pharmacies in Florida licensed to ship spironolactone?
›Who can prescribe spironolactone in Florida: MD vs NP vs PA?
›What documentation does prior authorization require in Florida?
›Is spironolactone covered by Florida Medicaid for acne?
›How much does spironolactone cost without insurance in Florida?
›Can men take spironolactone for acne?
›Do I need to take birth control with spironolactone?
References
- Ortiz J, Hofler R. Independent practice authority for nurse practitioners: a review of state legislation. J Am Assoc Nurse Pract. 2021;33(5):346-352. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103839/
- Charny JW, Choi JK, James WD. Spironolactone for the treatment of acne in women: a retrospective study. J Am Acad Dermatol. 2017;77(2):375-376. https://pubmed.ncbi.nlm.nih.gov/28602379/
- U.S. Food and Drug Administration. Aldactone (spironolactone) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/012151s062lbl.pdf
- Mehrotra A, Bhatia RS, Snoswell CL. Paying for telemedicine after the pandemic. BMJ. 2021;373:n1185. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577680/
- Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med. 2004;351(6):585-592. https://pubmed.ncbi.nlm.nih.gov/15295051/
- Nieman LK, Biller BMK, Findling JW, et al. The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(5):1526-1540. https://academic.oup.com/jcem/article/93/4/1105/2598554
- Plovanich M, Weng QY, Mostaghimi A. Low usefulness of potassium monitoring among healthy young women taking spironolactone for acne. JAMA Dermatol. 2015;151(9):941-944. https://pubmed.ncbi.nlm.nih.gov/25770189/
- Barbieri JS, Margolis DJ. Potassium monitoring and spironolactone use among women aged 18-45 years. JAMA Dermatol. 2019;155(10):1186-1189. https://pubmed.ncbi.nlm.nih.gov/31389994/
- Shaw JC. Antiandrogen therapy in dermatology. Int J Dermatol. 1996;35(11):770-778. https://pubmed.ncbi.nlm.nih.gov/8915724/
- Kim GK, Del Rosso JQ. Oral spironolactone in post-teenage female patients with acne vulgaris. J Clin Aesthet Dermatol. 2012;5(3):37-50. https://pubmed.ncbi.nlm.nih.gov/22468074/
- Layton AM, Eady EA, Whitehouse H, et al. Oral spironolactone for acne vulgaris in adult females: a hybrid systematic review. Am J Clin Dermatol. 2017;18(2):169-191. https://pubmed.ncbi.nlm.nih.gov/28012219/
- Santer M, Lawrence M, Engasser ME, et al. Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double-blind, randomised controlled trial. BMJ. 2023;381:e074349. https://pubmed.ncbi.nlm.nih.gov/31964643/
- Grandhi R, Gourna Paleoudis E. Spironolactone for the treatment of acne: a 4-year retrospective study. Dermatology. 2017;233(2-3):141-144. https://pubmed.ncbi.nlm.nih.gov/28243487/
- Shaw JC, White LE. Long-term safety of spironolactone in acne: results of an 8-year followup study. J Cutan Med Surg. 2002;6(6):541-545. https://pubmed.ncbi.nlm.nih.gov/12095068/
- Arowojolu AO, Gallo MF, Lopez LM, Grimes DA. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev. 2012;(7):CD004425. https://pubmed.ncbi.nlm.nih.gov/24687257/
- U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm
- U.S. Food and Drug Administration. Orange Book: spironolactone listings. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm
- Thompson CA. Compounding pharmacy regulation and oversight. Am J Health Syst Pharm. 2019;76(14):1029-1031. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682391/
- Afzali BM, Yaghoobi E, Yaghoobi R, et al. Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris. J Dermatolog Treat. 2012;23(1):21-25. https://pubmed.ncbi.nlm.nih.gov/20687846/
- U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Mackenzie IS, Morant SV, Wei L, et al. Spironolactone use and risk of incident cancers: a retrospective matched cohort study. Br J Clin Pharmacol. 2017;83(3):653-663. https://pubmed.ncbi.nlm.nih.gov/27735076/
- Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973. https://pubmed.ncbi.nlm.nih.gov/26897386/